Organization Profile

You just read:

Resverlogix Announces Second Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone (RVX-208)

News provided by

Resverlogix Corp.

Dec 05, 2016, 12:13 ET